179 related articles for article (PubMed ID: 36555631)
21. Glibenclamide induces apoptosis by activating reactive oxygen species dependent JNK pathway in hepatocellular carcinoma cells.
Yan B; Peng Z; Xing X; Du C
Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28801533
[TBL] [Abstract][Full Text] [Related]
22. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound.
Hu Z; Lv G; Li Y; Li E; Li H; Zhou Q; Yang B; Cao W
J Exp Clin Cancer Res; 2016 Apr; 35():71. PubMed ID: 27102814
[TBL] [Abstract][Full Text] [Related]
24. Activation of reactive oxygen species-mediated mitogen-activated protein kinases pathway regulates both extrinsic and intrinsic apoptosis induced by arctigenin in Hep G2.
Lu Z; Zhou H; Zhang S; Dai W; Zhang Y; Hong L; Chen F; Cao J
J Pharm Pharmacol; 2020 Jan; 72(1):29-43. PubMed ID: 31617221
[TBL] [Abstract][Full Text] [Related]
25. Antitumor effect of matrine in human hepatoma G2 cells by inducing apoptosis and autophagy.
Zhang JQ; Li YM; Liu T; He WT; Chen YT; Chen XH; Li X; Zhou WC; Yi JF; Ren ZJ
World J Gastroenterol; 2010 Sep; 16(34):4281-90. PubMed ID: 20818811
[TBL] [Abstract][Full Text] [Related]
26. Discovery of penipanoid C-inspired 2-(3,4,5-trimethoxybenzoyl)quinazolin-4(3H)-one derivatives as potential anticancer agents by inhibiting cell proliferation and inducing apoptosis in hepatocellular carcinoma cells.
Wang CJ; Guo X; Zhai RQ; Sun C; Xiao G; Chen J; Wei MY; Shao CL; Gu Y
Eur J Med Chem; 2021 Nov; 224():113671. PubMed ID: 34237623
[TBL] [Abstract][Full Text] [Related]
27. Matrine-induced autophagy regulated by p53 through AMP-activated protein kinase in human hepatoma cells.
Xie SB; He XX; Yao SK
Int J Oncol; 2015 Aug; 47(2):517-26. PubMed ID: 26034977
[TBL] [Abstract][Full Text] [Related]
28. The activation of p38 and JNK by ROS, contribute to OLO-2-mediated intrinsic apoptosis in human hepatocellular carcinoma cells.
Zhang Z; Zhang C; Ding Y; Zhao Q; Yang L; Ling J; Liu L; Ji H; Zhang Y
Food Chem Toxicol; 2014 Jan; 63():38-47. PubMed ID: 24211866
[TBL] [Abstract][Full Text] [Related]
29. Isomalto oligosaccharide sulfate inhibits tumor growth and metastasis of hepatocellular carcinoma in nude mice.
Xiao CL; Tao ZH; Guo L; Li WW; Wan JL; Sun HC; Wang L; Tang ZY; Fan J; Wu WZ
BMC Cancer; 2011 Apr; 11():150. PubMed ID: 21513518
[TBL] [Abstract][Full Text] [Related]
30. Decrease of MLK4 prevents hepatocellular carcinoma (HCC) through reducing metastasis and inducing apoptosis regulated by ROS/MAPKs signaling.
Li Y; Zuo H; Wang H; Hu A
Biomed Pharmacother; 2019 Aug; 116():108749. PubMed ID: 31071576
[TBL] [Abstract][Full Text] [Related]
31. Neochamaejasmin A Induces Mitochondrial-Mediated Apoptosis in Human Hepatoma Cells via ROS-Dependent Activation of the ERK1/2/JNK Signaling Pathway.
Ding Y; Xie Q; Liu W; Pan Z; Fan X; Chen X; Li M; Zhao W; Li D; Zheng Q
Oxid Med Cell Longev; 2020; 2020():3237150. PubMed ID: 32411325
[TBL] [Abstract][Full Text] [Related]
32. A novel benzimidazole derivative, MBIC inhibits tumor growth and promotes apoptosis via activation of ROS-dependent JNK signaling pathway in hepatocellular carcinoma.
Dai X; Wang L; Deivasigamni A; Looi CY; Karthikeyan C; Trivedi P; Chinnathambi A; Alharbi SA; Arfuso F; Dharmarajan A; Goh BC; Hui KM; Kumar AP; Mustafa MR; Sethi G
Oncotarget; 2017 Feb; 8(8):12831-12842. PubMed ID: 28086233
[TBL] [Abstract][Full Text] [Related]
33. {2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl-ethyl]-1H-indol-3-yl}-acetic acid methyl ester (MIAM) inhibited human hepatocellular carcinoma growth through upregulation of Sirtuin-3 (SIRT3).
Li Y; Wang W; Xu X; Sun S; Qu XJ
Biomed Pharmacother; 2015 Feb; 69():125-32. PubMed ID: 25661348
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of cancer cell growth by oleanolic acid in multidrug resistant liver carcinoma is mediated via suppression of cancer cell migration and invasion, mitochondrial apoptosis, G2/M cell cycle arrest and deactivation of JNK/p38 signalling pathway.
Gao C; Li X; Yu S; Liang L
J BUON; 2019; 24(5):1964-1969. PubMed ID: 31786862
[TBL] [Abstract][Full Text] [Related]
35. III-10, a newly synthesized flavonoid, induces cell apoptosis with the involvement of reactive oxygen species-mitochondria pathway in human hepatocellular carcinoma cells.
Dai Q; Yin Q; Zhao Y; Guo R; Li Z; Ma S; Lu N
Eur J Pharmacol; 2015 Oct; 764():353-362. PubMed ID: 26164795
[TBL] [Abstract][Full Text] [Related]
36. Repressing of NHERF1 inhibits liver cancer progression by promoting the production of ROS.
Sun J; Li P; Yang J
Biochem Biophys Res Commun; 2019 Jan; 509(1):8-15. PubMed ID: 30581004
[TBL] [Abstract][Full Text] [Related]
37. Sinoporphyrin sodium based sonodynamic therapy induces anti-tumor effects in hepatocellular carcinoma and activates p53/caspase 3 axis.
Li E; Sun Y; Lv G; Li Y; Zhang Z; Hu Z; Cao W
Int J Biochem Cell Biol; 2019 Aug; 113():104-114. PubMed ID: 30660690
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
[TBL] [Abstract][Full Text] [Related]
39. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
Zhao P; Chen L; Li LH; Wei ZF; Tong B; Jia YG; Kong LY; Xia YF; Dai Y
BMC Cancer; 2014 Dec; 14():987. PubMed ID: 25527123
[TBL] [Abstract][Full Text] [Related]
40. 2-(Naphthalene-2-thio)-5,8-dimethoxy-1,4-naphthoquinone induces apoptosis via ROS-mediated MAPK, AKT, and STAT3 signaling pathways in HepG2 human hepatocellular carcinoma cells.
Liu Y; Luo YH; Li SM; Shen GN; Wang JR; Zhang Y; Feng YC; Xu WT; Zhang Y; Zhang T; Xue H; Wang HX; Cui Y; Wang Y; Jin CH
Drug Chem Toxicol; 2022 Jan; 45(1):33-43. PubMed ID: 35100937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
